<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39359799</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2049-0801</ISSN><JournalIssue CitedMedium="Print"><Volume>86</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Annals of medicine and surgery (2012)</Title><ISOAbbreviation>Ann Med Surg (Lond)</ISOAbbreviation></Journal><ArticleTitle>Disease X and COVID-19: turning lessons from India and the world into policy recommendations.</ArticleTitle><Pagination><StartPage>5914</StartPage><EndPage>5921</EndPage><MedlinePgn>5914-5921</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/MS9.0000000000002391</ELocationID><Abstract><AbstractText>Disease X is caused by pathogen X, an unknown infectious agent that can potentially trigger an epidemic or pandemic. Pathogen X might be any pathogen, including bacteria, viruses, parasites, fungi, and prions. WHO uses the term 'Disease X' for any new emerging disease caused by an unknown pathogen X. Disease X stands for any possible future pandemic in WHO's shortlist of high-priority diseases. This review looks at the manifestations of the recent COVID-19 epidemic as the first Disease X to evaluate what has happened and to learn from what went wrong in India and worldwide. To this end, a summary is presented of response measures by governments, often lacking flows of information, discrepancies in the views of experts and decisions of policymakers, and undesirable variations in individual and collective behavior and their consequences. The elements of combating Disease X in a world with considerable inequalities in relevant knowledge, expertise, information, quality of governance, and financial possibilities are discussed. Based on this, recommendations are given for an innovative global pandemic preparedness system.</AbstractText><CopyrightInformation>Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bardhan</LastName><ForeName>Mainak</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Bacteriology, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Miami Cancer Institute, Baptist Health South Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ray</LastName><ForeName>Ishita</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Mahatma Gandhi Memorial Medical College, Indore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roy</LastName><ForeName>Shubhajeet</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Medical Sciences, King George's Medical University, Lucknow.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roy</LastName><ForeName>Priyanka</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Chief Inspector of Factories/ Deputy Director (Medical) and Certifying Surgeon, Directorate of Factories, Department of Labor, Government of West Bengal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thanneeru</LastName><ForeName>Priya</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Gandhi Medical College, Secunderabad, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Twayana</LastName><ForeName>Anu Radha</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Kathmandu University School of Medical Sciences, Dhulikhel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prasad</LastName><ForeName>Sakshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Pirogov Memorial Medical University, Vinnytsya, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bardhan</LastName><ForeName>Mayukh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Regional Institute of Medical Sciences, Imphal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anand</LastName><ForeName>Ayush</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Miami Cancer Institute, Baptist Health South Florida, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Med Surg (Lond)</MedlineTA><NlmUniqueID>101616869</NlmUniqueID><ISSNLinking>2049-0801</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Disease X</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">zoonotic diseases</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>4</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39359799</ArticleId><ArticleId IdType="pmc">PMC11444564</ArticleId><ArticleId IdType="doi">10.1097/MS9.0000000000002391</ArticleId><ArticleId IdType="pii">AMSU-D-23-02452</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization . Prioritizing diseases for research and development in emergency contexts [Internet]. World Health Organisation. Accessed 4 May 2024.
https://www.who.int/activities/prioritizing-diseases-for-research-and-development-in-emergency-contexts</Citation></Reference><Reference><Citation>Simpson S, Kaufmann MC, Glozman V, et al. . Disease X: accelerating the development of medical countermeasures for the next pandemic. Lancet Infect Dis 2020;20:e108–e115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7158580</ArticleId><ArticleId IdType="pubmed">32197097</ArticleId></ArticleIdList></Reference><Reference><Citation>Possas C, Marques ETA, Risi JB, et al. . COVID-19 and future disease X in circular economy transition: redesigning pandemic preparedness to prevent a global disaster. Circ Econ Sustain 2021;1:1463–1478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8238518</ArticleId><ArticleId IdType="pubmed">34888566</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan FMA, Hasan MM, Kazmi Z, et al. . Ebola and COVID-19 in Democratic Republic of Congo: grappling with two plagues at once. Trop Med Health 2021;49:1–4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8383245</ArticleId><ArticleId IdType="pubmed">34429168</ArticleId></ArticleIdList></Reference><Reference><Citation>Bardhan M, Pramanik D, Riyaz R, et al. . Dual burden of Zika and COVID-19 in India: challenges, opportunities and recommendations. Trop Med Health 2021;49:1–4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8520823</ArticleId><ArticleId IdType="pubmed">34657633</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa ACDS, Hasan MM, Xenophontos E, et al. . COVID-19 and Zika: an emerging dilemma for Brazil. J Med Virol 2021;93:4124–4126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8251083</ArticleId><ArticleId IdType="pubmed">33837977</ArticleId></ArticleIdList></Reference><Reference><Citation>Aborode AT, Corriero AC, Fajemisin EA, et al. . Dengue and Coronavirus disease (COVID-19) syndemic: double threat to an overburdened healthcare system in Africa. Int J Health Plann Manage 2022;37:1851–1854.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8653274</ArticleId><ArticleId IdType="pubmed">34523165</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousaf A, Khan FMA, Hasan MM, et al. . Dengue, measles, and COVID-19: a threefold challenge to public health security in Pakistan. Ethics, Med Public Heal 2021;19:100704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8249682</ArticleId><ArticleId IdType="pubmed">34230890</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhary OP, Singh I, Patra G. Aerosol transmission of SARS-CoV-2: the unresolved paradox. Travel Med Infect Dis 2020;37:101869.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7471761</ArticleId><ArticleId IdType="pubmed">32891726</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiavo R, May Leung M, Brown M. Communicating risk and promoting disease mitigation measures in epidemics and emerging disease settings. Pathog Glob Health 2014;108:76–94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4005587</ArticleId><ArticleId IdType="pubmed">24649867</ArticleId></ArticleIdList></Reference><Reference><Citation>Iserson KV. The next pandemic: prepare for “Disease X”. West J Emerg Med 2020;21:756.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390567</ArticleId><ArticleId IdType="pubmed">32726236</ArticleId></ArticleIdList></Reference><Reference><Citation>Burki T. Known unknowns and unknown unknowns. Lancet Infect Dis 2018;18:385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7129054</ArticleId><ArticleId IdType="pubmed">29582769</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang S, Shi ZL. The first disease X is caused by a highly transmissible acute respiratory syndrome coronavirus. Virol Sin 2020;35:263–265.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7091198</ArticleId><ArticleId IdType="pubmed">32060789</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahir MJ, Sawal I, Essar MY, et al. . Disease X: a hidden but inevitable creeping danger. Infect Control Hosp Epidemiol 2022;43:1758–1759.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8367867</ArticleId><ArticleId IdType="pubmed">34308811</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones KE, Patel NG, Levy MA. Global trends in emerging infectious diseases. Nature 2008;451:990–993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5960580</ArticleId><ArticleId IdType="pubmed">18288193</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauch S, Jasny E, Schmidt KE, et al. . New vaccine technologies to combat outbreak situations. Front Immunol 2018;9:1963.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6156540</ArticleId><ArticleId IdType="pubmed">30283434</ArticleId></ArticleIdList></Reference><Reference><Citation>Centre for Health Security . Johns Hopkins Bloomberg School of Public Health The characteristics of pandemic pathogens. http://www.centerforhealthsecurity.org/our-work/pubs_archive/pubs-pdfs/2018/180510-pandemic-pathogens-report.pdf</Citation></Reference><Reference><Citation>Woolhouse MEJ, Adair K, Brierley L. RNA viruses: a case study of the biology of emerging infectious diseases. Microbiol Spectr 2013;1:10.1128/microbiolspec.OH-0001-2012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6157708</ArticleId><ArticleId IdType="pubmed">26184815</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreuder Johnson C, Hitchens PL, Smiley Evans T. Spillover and pandemic properties of zoonotic viruses with high host plasticity. Sci Rep 2015;5:14830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4595845</ArticleId><ArticleId IdType="pubmed">26445169</ArticleId></ArticleIdList></Reference><Reference><Citation>Morse SS, Mazet JAK, Woolhouse M, et al. . Prediction and prevention of the next pandemic zoonosis. Lancet 2012;380:1956–1965.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3712877</ArticleId><ArticleId IdType="pubmed">23200504</ArticleId></ArticleIdList></Reference><Reference><Citation>Salyer SJ, Silver R, Simone K, et al. . Prioritizing zoonoses for global health capacity building—themes from One Health Zoonotic Disease Workshops in 7 countries, 2014–2016. Emerg Infect Dis 2017;23:S55–S64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5711306</ArticleId><ArticleId IdType="pubmed">29155664</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly TR, Karesh WB, Johnson CK. One health proof of concept: bringing a transdisciplinary approach to surveillance for zoonotic viruses at the human-wild animal interface. Prev Vet Med 2017;137(Pt B):112–118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7132382</ArticleId><ArticleId IdType="pubmed">28034593</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwind JS, Goldstein T, Thomas K, et al. . Capacity building efforts and perceptions for wildlife surveillance to detect zoonotic pathogens: comparing stakeholder perspectives. BMC Public Health 2014;14:684.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4096412</ArticleId><ArticleId IdType="pubmed">24996851</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelwhab EM, Mettenleiter TC. Zoonotic animal influenza virus and potential mixing vessel hosts. Viruses 2023;15:980.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10145017</ArticleId><ArticleId IdType="pubmed">37112960</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P, Yang XL, Wang XG, et al. . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579:270–273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee P, Nair P, Chersich M, et al. . One Health, “Disease X” and the challenge of “Unknown” unknowns. Indian J Med Res 2021;153:264–271.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8204831</ArticleId><ArticleId IdType="pubmed">33906988</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolhouse MEJ. Emerging diseases go global. Nature 2008;451:898–899.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095335</ArticleId><ArticleId IdType="pubmed">18288175</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolhouse M, Scott F, Hudson Z, et al. . Human viruses: discovery and emergence. Philoso Trans R Soc Lond B Biol Sci 2012;367:2864–2871.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3427559</ArticleId><ArticleId IdType="pubmed">22966141</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe ND, Dunavan CP, Diamond J. Origins of major human infectious diseases. Nature 2007;447:279–283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095142</ArticleId><ArticleId IdType="pubmed">17507975</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan MM. Epidemiology of rabies. Nature 1969;221:421–425.</Citation><ArticleIdList><ArticleId IdType="pubmed">5784418</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudarshan MK, Madhusudana SN, Mahendra BJ, et al. . Assessing the burden of human rabies in India: results of a national multi-center epidemiological survey. Int J Infec Dis 2007;11:29–35.</Citation><ArticleIdList><ArticleId IdType="pubmed">16678463</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhillon GP, Raina VK. Epidemiology of Japanese encephalitis in context with Indian scenario. J Indian Med Assoc 2008;106:660–663.</Citation><ArticleIdList><ArticleId IdType="pubmed">19552100</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakkar M, Chaturvedi S, Saxena VK, et al. . Identifying sources, pathways and risk drivers in ecosystems of Japanese Encephalitis in an epidemic-prone north Indian district. PLoS One 2017;12:e0175745.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5412994</ArticleId><ArticleId IdType="pubmed">28463989</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Assessment of risk associated with influenza A(H5N8) virus. Accessed 27 February 2021. http://www.who.int/influenza/human_animal_interface/avian_influenza/riskassessment_AH5N8_201611/en/</Citation></Reference><Reference><Citation>Abaza H, Agadi K, Anand A, et al. . Clinical manifestations of Monkeypox. Adv Exp Med Biol 2023;1410:7–11.</Citation><ArticleIdList><ArticleId IdType="pubmed">36396927</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard M, Herfst S, van den Brand JMA, et al. . Low virulence and lack of airborne transmission of the Dutch Highly Pathogenic Avian Influenza Virus H5N8 in Ferrets. PLoS One 2015;10:e0129827.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4474857</ArticleId><ArticleId IdType="pubmed">26090682</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan BS, Russier M, Jeevan T, et al. . Novel highly pathogenic avian A(H5N2) and A(H5N8) influenza viruses of Clade 2.3.4.4 from North America have limited capacity for replication and transmission in mammals. mSphere 2016;1:e00003–e00016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4894690</ArticleId><ArticleId IdType="pubmed">27303732</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulit-Penaloza JA, Sun X, Creager HM, et al. . Pathogenesis and transmission of novel highly pathogenic Avian Influenza H5N2 and H5N8 viruses in ferrets and mice. J Virol 2015;89:10286–10293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4580194</ArticleId><ArticleId IdType="pubmed">26223637</ArticleId></ArticleIdList></Reference><Reference><Citation>European Centre for Disease Prevention and Control . First identification of human cases of avian influenza A(H5N8) infection.Accessed 27 February 2021.
https://www.ecdc.europa.eu/sites/default/files/documents/First-identification-human-casesavian-influenza-A-H5N8-infection.pdf</Citation></Reference><Reference><Citation>Manna S, Satapathy P, Balasubramanian S, et al. . Beyond zoonosis: a one health exploration of Nipah virus clinical spectrum. The Evidence 2024;2:1. 10.61505/evidence.2024.2.1.13</Citation><ArticleIdList><ArticleId IdType="doi">10.61505/evidence.2024.2.1.13</ArticleId></ArticleIdList></Reference><Reference><Citation>natureportfolio . Fehervari Z Origin story. Accessed 7 March 2021.
https://www.nature.com/articles/d42859-018-00008-6</Citation></Reference><Reference><Citation>Agarwal K, Srivastava S, Singh V, et al. . One health concept and its applications in clinical practice: a comprehensive review. The Evidence 2024;2:1.</Citation></Reference><Reference><Citation>Peeters M, Honoré C, Huet T, et al. . Isolation and partial characterization of an HIV-related virus occurring naturally in chimpanzees in Gabon. AIDS 1989;3:625–630.</Citation><ArticleIdList><ArticleId IdType="pubmed">2512955</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao F, Bailes E, Robertson DL, et al. . Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 1999;397:436–441.</Citation><ArticleIdList><ArticleId IdType="pubmed">9989410</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Pneumonia of unknown cause- China [Internet]. World Health Organisation; 2020. Accessed 4 May 2024.
https://www.who.int/emergencies/disease-outbreak-news/item/2020-DON229</Citation></Reference><Reference><Citation>THE WIRE . G20 Leaders’ Commitments Fall Far Short of Expectations [Internet]. WIRE. Accessed 4 May 2024.
https://thewire.in/political-economy/g20-leaders-commitments-fall-far-short-of-expectations</Citation></Reference><Reference><Citation>THE WIRE . The G7 Is Prolonging the Pandemic, Here’s What We Need to End It [Internet]. WIRE. Accessed 4 May 2024. https://thewire.in/health/vaccine-internationalism-progressive-international-covid-19-pandemic-g7</Citation></Reference><Reference><Citation>EcoHealth Alliance . Disease X: The Next Pandemic [Internet]. EcoHealth Alliance. Accessed 2 October 2022.
https://www.ecohealthalliance.org/2018/03/disease-x.</Citation></Reference><Reference><Citation>GLOBAL VIROME PROJECT . GVP marks the beginning of the end of the pandemic era [Internet]. Global Virome Project. Accessed 2 October 2022. https://www.globalviromeproject.org/why-we-exist.</Citation></Reference><Reference><Citation>World Health Organization . International Health Regulations [Internet]. World Health Organization; 2005. Accessed 2 October 2022. https://www.who.int/publications/i/item/9789241580410</Citation></Reference><Reference><Citation>CDC . Global Health Protection and Security [Internet]. Centers for Disease Control and Prevention. Accessed 2 October 2022. https://www.cdc.gov/globalhealth/healthprotection</Citation></Reference><Reference><Citation>OECD . OECD Policy Responses to Coronavirus (COVID-19) First lessons from government evaluations of COVID-19 responses: A synthesis, [Internet]. OECD; 2022. Accessed 2 October 2022. https://www.oecd.org/coronavirus/policy-responses/first-lessons-from-government-evaluations-of-covid-19-responses-a-synthesis-483507d6/.</Citation></Reference><Reference><Citation>Carroll D, Morzaria S, Briand S. Preventing the next pandemic: the power of a global viral surveillance network. BMJ 2021;372:n485.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7953426</ArticleId><ArticleId IdType="pubmed">33712471</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahir M, Sawal I, Essar M, et al. . Disease X: a hidden but inevitable creeping danger. Infect Control Hospital Epidemiol 2022;43:1758–1759.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8367867</ArticleId><ArticleId IdType="pubmed">34308811</ArticleId></ArticleIdList></Reference><Reference><Citation>Priyanka, Chopra H, Choudhary OP. mRNA vaccines as an armor to combat the infectious diseases. Travel Med Infect Dis 2023;52:102550.</Citation><ArticleIdList><ArticleId IdType="pubmed">36754340</ArticleId></ArticleIdList></Reference><Reference><Citation>Duke . Covax released draft allocations for the first half of 2021 weekly covid vaccine research update. Duke Global Health Innovation Center; 2021. Accessed 2 October 2022. https://dukeghic.org/2021/02/08/1467/</Citation></Reference><Reference><Citation>Simonovich SD, Aquino E, Lattner C, et al. . US Nurses’ challenges with personal protective equipment during COVID-19: interview findings from the frontline workforce. Psych 2022;4:226–237.</Citation></Reference><Reference><Citation>Ghosh S, Moledina N, Hasan MM, et al. . Colossal challenges to healthcare workers combating the second wave of coronavirus disease 2019 (COVID-19) in India. Infect Control Hosp Epidemiol 2022;43:1302–1303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8193204</ArticleId><ArticleId IdType="pubmed">34075871</ArticleId></ArticleIdList></Reference><Reference><Citation>Rackimuthu S, Hasan MM, Bardhan M, et al. . COVID-19 vaccination strategies and policies in India: the need for further re-evaluation is a pressing priority. Int J Health Plann Manage 2022;37:1847–1850.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8652663</ArticleId><ArticleId IdType="pubmed">34510541</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhary OP, Priyanka, Singh I, et al. . Second wave of COVID-19 in India: dissection of the causes and lessons learnt. Travel Med Infect Dis 2021;43:102126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8214078</ArticleId><ArticleId IdType="pubmed">34144178</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar SU, Kumar DT, Christopher BP, et al. . The rise and impact of COVID-19 in India. Front Med 2020;7:250.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7256162</ArticleId><ArticleId IdType="pubmed">32574338</ArticleId></ArticleIdList></Reference><Reference><Citation>Streicker DG, Turmelle AS, Vonhof MJ, et al. . Host phylogeny constrains cross-species emergence and establishment of rabies virus in bats. Science 2010;329:676–679.</Citation><ArticleIdList><ArticleId IdType="pubmed">20689015</ArticleId></ArticleIdList></Reference><Reference><Citation>Parrish CR, Holmes EC, Morens DM, et al. . Cross-species virus transmission and the emergence of new epidemic diseases. Microbiol Mol Biol Rev 2008;72:457.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2546865</ArticleId><ArticleId IdType="pubmed">18772285</ArticleId></ArticleIdList></Reference><Reference><Citation>Bardhan M, Ray I, Roy S, et al. . Emerging zoonotic diseases and COVID-19 pandemic: global Perspective and Indian Scenario. Ann Med Surg 2023;85:3997–4004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10406085</ArticleId><ArticleId IdType="pubmed">37554903</ArticleId></ArticleIdList></Reference><Reference><Citation>Compton C. Getting to personalized cancer medicine. Cancer 2007;110:1641–1643.</Citation><ArticleIdList><ArticleId IdType="pubmed">17763370</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Maruggi G, Shan H, et al. . Advances in mRNA vaccines for infectious diseases. Front Immunol 2019;10:594.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6446947</ArticleId><ArticleId IdType="pubmed">30972078</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra H, Choudhary OP. MRNA vaccines as an armor to combat the infectious diseases. Travel Med Infect Dis 2023;52:102550.</Citation><ArticleIdList><ArticleId IdType="pubmed">36754340</ArticleId></ArticleIdList></Reference><Reference><Citation>Abusalah MAH, Chopra H, Sharma A, et al. . Nanovaccines: A game changing approach in the fight against infectious diseases. Biomed Pharmacother 2023;167:115597.</Citation><ArticleIdList><ArticleId IdType="pubmed">37783148</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocco P, Ayaz-Shah A, Messenger MP, et al. . Target Product Profiles for medical tests: a systematic review of current methods. BMC Med 2020;18:1–12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7212678</ArticleId><ArticleId IdType="pubmed">32389127</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Target product profiles [Internet]. World Health Organisation Accessed 4 May 2024. https://www.who.int/observatories/global-observatory-on-health-research-and-development/analyses-and-syntheses/target-product-profile/who-target-product-profiles</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>